MYX 4.50% $4.03 mayne pharma group limited

Ann: MAYNE PHARMA provides FDA update on generic NUVARING, page-52

  1. 904 Posts.
    lightbulb Created with Sketch. 146
    you are exactly right. Having worked in Houston and Alberta, let me tell you, the difference between US vs Commonwealth countries, from a corporate perspective, is under appreciated. US management at the "C" level will be the spring board for this company, and in the Regulatory space - it's a non-brainer and it's essential. The process has now begun fortunately.
    Last edited by Lithos: 16/10/21
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.